Comparison of Patients with Community-Acquired Pneumonia Who Did and Did not Receive Treatment in Accordance with the 2009 Pneumonia Guideline of Turkish Thoracic Society

被引:3
|
作者
Soylar, Oznur Kilic [1 ]
Kilinc, Oguz [1 ]
Ellidokuz, Hulya [2 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Chest Dis, Izmir, Turkey
[2] Dokuz Eylul Univ, Biostat Discipline, Dept Prevent Oncol, Izmir, Turkey
关键词
Community-acquired pneumonia; pneumonia treatment guideline; adherence with guideline;
D O I
10.5152/ttd.2015.4437
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not administered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment efficacy. MATERIAL AND METHODS: Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demographic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological findings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TURKEY Community Acquired Pneumonia). Taking into consideration the "Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009)," the patients recorded in the database were evaluated in terms of conformity to the guideline. RESULTS: This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No significant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treatment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treatment resulted in death in 8% of these patients. CONCLUSION: Hospital stay length, treatment cost, and treatment efficacy were similar in patients who were and were not administered treatment in accordance with the guideline.
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [1] Comparison of health care associated pneumonia and community acquired pneumonia in Turkish Thoracic Society pneumonia database
    Gunduz, Canan
    Tasbakan, Sezai
    Sayiner, Abdullah
    Coskun, Aysin Sakar
    Durmaz, Feride
    Cilli, Aykut
    Celenk, Burcu
    Kilinc, Oguz
    Salman, Seda
    Hazar, Armagan
    Tokgoz, Fatma
    Kokturk, Nurdan
    Nazik, Sakine
    Filiz, Ayten
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] Thoracic empyema in patients with community-acquired pneumonia
    Ahmed, Rabia A.
    Marrie, Thomas J.
    Huang, Jane Q.
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (10): : 877 - 883
  • [3] British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
    Lim, W. S.
    Smith, D. L.
    Wise, M. P.
    Welham, S. A.
    THORAX, 2015, 70 (07) : 698 - 700
  • [4] Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia
    Campbell, GD
    CHEST, 1999, 115 (03) : 14S - 18S
  • [5] British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
    Lim, W. S.
    Smith, D. L.
    Wise, M. P.
    Welham, S. A.
    BMJ OPEN RESPIRATORY RESEARCH, 2015, 2 (01): : 1 - 3
  • [6] Treatment of hospitalized patients with community-acquired pneumonia
    Leenders, ACAP
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) : 109 - 110
  • [7] Treatment of community-acquired pneumonia in hospitalised patients
    Mulazimoglu, L
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 : S63 - S70
  • [8] THE HOSPITAL MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA - RECOMMENDATIONS OF THE BRITISH THORACIC SOCIETY
    HARRISON, BDW
    FARR, BM
    CONNOLLY, CK
    MACFARLANE, JT
    SELKON, JB
    BARTLETT, CLR
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1987, 21 (04): : 267 - 269
  • [9] Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
    Metlay, Joshua P.
    Waterer, Grant W.
    Long, Ann C.
    Anzueto, Antonio
    Brozek, Jan
    Crothers, Kristina
    Cooley, Laura A.
    Dean, Nathan C.
    Fine, Michael J.
    Flanders, Scott A.
    Griffin, Marie R.
    Metersky, Mark L.
    Musher, Daniel M.
    Restrepo, Marcos, I
    Whitney, Cynthia G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (07) : E45 - E67
  • [10] COMPARISON OF CEFADROXIL AND CEPHALEXIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
    BLASER, MJ
    KLAUS, BD
    JACOBSON, JA
    KASWORM, E
    LAFORCE, FM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) : 163 - 167